ARQTArcutis Biotherapeutics, Inc.May 7, 2026Q1 2026
Read transcript →Arcutis Biotherapeutics, Inc. (ARQT) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$26.00
+0.44%
Mkt Cap $3.48B
ARQTArcutis Biotherapeutics, Inc.May 7, 2026ARQTArcutis Biotherapeutics, Inc.Feb 26, 2026Q4 2025
Read transcript →ARQTArcutis Biotherapeutics, Inc.Oct 28, 2025Q3 2025
Read transcript →ARQTArcutis Biotherapeutics, Inc.Aug 7, 2025Q2 2025
Read transcript →ARQTArcutis Biotherapeutics, Inc.May 6, 2025Q1 2025
Read transcript →ARQTArcutis Biotherapeutics, Inc.Feb 25, 2025Q4 2024
Read transcript →ARQTArcutis Biotherapeutics, Inc.Nov 7, 2024Q3 2024
Read transcript →ARQTArcutis Biotherapeutics, Inc.Aug 15, 2024Q2 2024
Read transcript →ARQTArcutis Biotherapeutics, Inc.May 14, 2024Q1 2024
Read transcript →ARQTArcutis Biotherapeutics, Inc.Feb 27, 2024Q4 2023
Read transcript →ARQTArcutis Biotherapeutics, Inc.Nov 3, 2023Q3 2023
Read transcript →ARQTArcutis Biotherapeutics, Inc.Aug 8, 2023Q2 2023
Read transcript →ARQTArcutis Biotherapeutics, Inc.May 13, 2023Q1 2023
Read transcript →ARQTArcutis Biotherapeutics, Inc.Feb 28, 2023Q4 2022
Read transcript →ARQTArcutis Biotherapeutics, Inc.Nov 14, 2022Q3 2022
Read transcript →